Freemelt (FREEM) Investor Update summary

Strategic focus and business development

• Emphasizes a differentiated approach in additive manufacturing, focusing on open-source, modular machine design for efficiency and customer value.

• Concentrates on three core verticals: defense, energy (especially fusion), and medtech, all experiencing structural growth.

• Achieved record order intake and invoicing in 2025, with 12 machines sold year-to-date and 40 machines installed globally.

• Outsourced assembly to Scanfil for a more agile supply chain and established a technical advisory board to align with industry needs.

• Entered the Chinese market, leveraging high adoption rates of additive manufacturing and strategic partnerships.

Fusion energy and technological advancements

• Fusion energy is entering a new era, driven by private investment and government support, with over $10 billion in private capital and significant public funding increases.

• Additive manufacturing, especially with tungsten, is critical for plasma-facing components in fusion reactors, offering design freedom and superior material properties.

• Freemelt's technology demonstrated 30% less tritium retention in tungsten components, a potential game-changer for fusion economics.

• Major breakthroughs include divertor technology, high-temperature superconducting magnets, and AI for plasma management.

• The fusion industry is rapidly growing, with 55 global companies and increasing geopolitical interest in energy security.

Medtech and market opportunities

• Orthopedic implant market is growing, with additive manufacturing expected to reach 20% of total implants by 2032.

• Proof of concept underway with a major implant OEM, potentially leading to over 100 machine sales in a positive scenario.

• Customer is already experienced in additive manufacturing, focusing on new applications and future growth rather than replacement.